» Articles » PMID: 37322524

A Review of Duhuo Jisheng Decoction Mechanisms in Intervertebral Disc Degeneration in Vitro and Animal Studies

Overview
Publisher Biomed Central
Specialty Orthopedics
Date 2023 Jun 15
PMID 37322524
Authors
Affiliations
Soon will be listed here.
Abstract

Intervertebral disc degeneration (IVDD) has become a serious public health problem, placing a heavy burden on society and the healthcare system. Its pathogenesis is not completely clear and may be closely related to mechanical damage, inflammatory factors, oxidative stress and death of nucleus pulposus cells (NPCs). The treatment of IVDD mainly includes conservative treatment and surgery. Conservative treatment is based on hormonal and anti-inflammatory drugs and massage techniques, which can relieve the pain symptoms to a certain extent, but cannot solve the problem from the root cause. Surgical treatment is mainly by removing the herniated nucleus pulposus, but it is more traumatic for IVDD patients, expensive and not suitable for all patients. Therefore, it is extremely important to clarify the pathogenesis of IVDD, to find an effective and convenient treatment and to further elaborate its mechanism of action. The effectiveness of traditional Chinese medicine in the treatment of IVDD has been well demonstrated in clinical medical research. We have been working on the Chinese herbal formula Duhuo Jisheng Decoction, which is a common formula for the treatment of degenerative disc disease. Not only does it have significant clinical effects, but it also has few adverse effects. At present, we found that its mechanism of action mainly involves regulation of inflammatory factors, reduction of apoptosis and pyroptosis of NPCs, inhibition of extracellular matrix degradation, improvement of intestinal flora, etc. However, a few relevant articles have yet comprehensively and systematically summarized the mechanisms by which they exert their effect. Therefore, this paper will comprehensively and systematically explain on it. This is of great clinical significance and social value for elucidating the pathogenesis of IVDD and improving the symptoms of patients, and will provide a theoretical basis and scientific basis for the treatment of IVDD with traditional Chinese medicine.

Citing Articles

Analysis of Key Differential Metabolites in Intervertebral Disc Degeneration Based on Untargeted Metabolomics.

Zhou D, Zhang X, Lv J, Mei Y, Luo Y, Li F JOR Spine. 2025; 8(1):e70032.

PMID: 39781087 PMC: 11707616. DOI: 10.1002/jsp2.70032.


Targeting nucleus pulposus cell death in the treatment of intervertebral disc degeneration.

Sun H, Guo J, Xiong Z, Zhuang Y, Ning X, Liu M JOR Spine. 2024; 7(4):e70011.

PMID: 39703198 PMC: 11655182. DOI: 10.1002/jsp2.70011.


Identifying critical modules and biomarkers of intervertebral disc degeneration by using weighted gene co-expression network.

Zhou D, Liu T, Mei Y, Lv J, Cheng K, Cai W JOR Spine. 2024; 7(4):e70004.

PMID: 39430414 PMC: 11487274. DOI: 10.1002/jsp2.70004.


Integrated metagenomic and metabonomic mechanisms for the therapeutic effects of Duhuo Jisheng decoction on intervertebral disc degeneration.

Song C, Liu F, Mei Y, Cai W, Cheng K, Guo D PLoS One. 2024; 19(10):e0310014.

PMID: 39418241 PMC: 11486403. DOI: 10.1371/journal.pone.0310014.


Machine learning and single-cell analysis identify the mitophagy-associated gene TOMM22 as a potential diagnostic biomarker for intervertebral disc degeneration.

Wu Y, Wu S, Chen Z, Yang E, Yu H, Zhang G Heliyon. 2024; 10(17):e37378.

PMID: 39296040 PMC: 11407931. DOI: 10.1016/j.heliyon.2024.e37378.


References
1.
Li Z, Yang L, Tang S, Bian Y . Equity and Efficiency of Health Resource Allocation of Chinese Medicine in Mainland China: 2013-2017. Front Public Health. 2021; 8:579269. PMC: 7769806. DOI: 10.3389/fpubh.2020.579269. View

2.
Liao Z, Luo R, Li G, Song Y, Zhan S, Zhao K . Exosomes from mesenchymal stem cells modulate endoplasmic reticulum stress to protect against nucleus pulposus cell death and ameliorate intervertebral disc degeneration in vivo. Theranostics. 2019; 9(14):4084-4100. PMC: 6592170. DOI: 10.7150/thno.33638. View

3.
Zhang H, Yao S, Zhang Z, Zhou C, Fu F, Bian Y . Network Pharmacology and Experimental Validation to Reveal the Pharmacological Mechanisms of Liuwei Dihuang Decoction Against Intervertebral Disc Degeneration. Drug Des Devel Ther. 2021; 15:4911-4924. PMC: 8648103. DOI: 10.2147/DDDT.S338439. View

4.
Ding K, Hua F, Ding W . Gut Microbiome and Osteoporosis. Aging Dis. 2020; 11(2):438-447. PMC: 7069453. DOI: 10.14336/AD.2019.0523. View

5.
Zhang X, Zhang D, Jia H, Feng Q, Wang D, Liang D . The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nat Med. 2015; 21(8):895-905. DOI: 10.1038/nm.3914. View